Mackenzie Financial’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,878
Closed -$250K 1548
2022
Q3
$250K Sell
2,878
-179
-6% -$18.8K ﹤0.01% 1159
2022
Q2
$348K Sell
3,057
-16
-0.5% -$1.84K ﹤0.01% 1033
2022
Q1
$398K Buy
3,073
+156
+5% +$22.5K ﹤0.01% 1033
2021
Q4
$526K Sell
2,917
-151
-5% -$26.2K ﹤0.01% 994
2021
Q3
$455K Buy
3,068
+1,006
+49% +$154K ﹤0.01% 1012
2021
Q2
$312K Buy
+2,062
New +$287K ﹤0.01% 1064
2019
Q4
Sell
-18,310
Closed -$1.32M 1138
2019
Q3
$1.32M Sell
18,310
-15,700
-46% -$1.15M ﹤0.01% 675
2019
Q2
$2.93M Buy
34,010
+21,380
+169% +$1.74M 0.01% 551
2019
Q1
$1.02M Buy
+12,630
New +$945K ﹤0.01% 920

Other funds holding OMCL

Mackenzie Financial's OMCL Position: Q4 2022 in Review

Mackenzie Financial sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 2,878 shares — an estimated $250K sold.

Mackenzie Financial first reported a position in OMCL in Q1 2019 and held it in 9 quarters. The position peaked at $2.93M in Q2 2019. 328 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Mackenzie Financial reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Mackenzie Financial sold 2,878 Omnicell shares in Q4 2022, an estimated $250K.
  • Mackenzie Financial first reported a position in Omnicell in Q1 2019 and held it in 9 quarters.
  • Mackenzie Financial's Omnicell position peaked at $2.93M in Q2 2019.
  • 328 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Mackenzie Financial's 13F filing for Q4 2022, filed 14 Feb 2023.